Ultrasound Liver Package, Tuesday, March 23, 2021 19:00 CET
Ultrasound Assessment of Diffuse Liver Diseases
Background information:
Prevalence of diffuse liver disease is increasing globally and is now a worldwide problem.In addition to alcohol abuse or chronic hepatitis, other causes such as metabolic syndrome or liver-related conditions are emerging.
The wide variety of these causes and their impact on the liver require the combination of conventional ultrasound with dedicated techniques to deliver appropriate staging of the patient.
This webinar will review the use and diagnostic performance of techniques such as elastography for fibrosis or attenuation imaging for steatosis, including the last updates.
This webinar occurs now in the past. The recording is available. Click here to watch it now.
Why you should attend:
- Learn from Prof. V. Vilgrain and Dr. G. Ferraioli how to evaluate multiple aspects of diffuse liver disease using ultrasound imaging techniques on Canon Medical devices.
- Get practical tips from the examples discussed to increase your diagnostic confidence.
- Participate in the live Q&A session to find answers to your own questions.
Speaker: Prof. Valerie Vilgrain, MD, PhD
Head of Radiology Departement
Beaujon Hospital, APHP
Clichy, France
Background Information:
Head of Radiology at Beaujon University Hospital, Clichy, Université Paris 7, France.
Dr. Vilgrain is currently full professor of radiology at the University of Paris 7 Denis Diderot, France. She is a member of several national and international societies, inter alia RSNA (Radiological Society of North America), VS (European Society of Radiology), ESGAR (European Society of Gastro and Abdominal Radiology) and SFR (French Radiological Society).
Multi-Parametric Tools for Liver Disease Assessment
Prevalence of diffuse liver disease is increasing globally and is now a worldwide problem.
In addition to alcohol abuse or chronic hepatitis, other causes such as metabolic syndrome or liver-related conditions are emerging.
The wide variety of these causes and their impact on the liver require the combination of conventional ultrasound with dedicated techniques to deliver appropriate staging of the patient.
This information enables identification as well as prognosis and prioritization of treatment and follow-up.
Learning objectives of the presentation:
Learn from Prof. V. Vilgrain how to evaluate multiple aspects of diffuse liver disease using ultrasound imaging techniques on Canon Medical devices.
Head of Radiology Departement
Beaujon Hospital, APHP
Clichy, France
Background Information:
Head of Radiology at Beaujon University Hospital, Clichy, Université Paris 7, France.
Dr. Vilgrain is currently full professor of radiology at the University of Paris 7 Denis Diderot, France. She is a member of several national and international societies, inter alia RSNA (Radiological Society of North America), VS (European Society of Radiology), ESGAR (European Society of Gastro and Abdominal Radiology) and SFR (French Radiological Society).
Multi-Parametric Tools for Liver Disease Assessment
Prevalence of diffuse liver disease is increasing globally and is now a worldwide problem.
In addition to alcohol abuse or chronic hepatitis, other causes such as metabolic syndrome or liver-related conditions are emerging.
The wide variety of these causes and their impact on the liver require the combination of conventional ultrasound with dedicated techniques to deliver appropriate staging of the patient.
This information enables identification as well as prognosis and prioritization of treatment and follow-up.
Learning objectives of the presentation:
Learn from Prof. V. Vilgrain how to evaluate multiple aspects of diffuse liver disease using ultrasound imaging techniques on Canon Medical devices.
Speaker Dr. Giovanna Ferraioli, MD,
Reference Doctor, Ultrasound Unit, Department of Infectious and Tropical Diseases Foundation IRCCS
Policlinico San Matteo, University of Pavia
Pavia, Italy
Background Information:
Reference Doctor, Ultrasound Unit, Department of Infectious and Tropical Diseases Foundation IRCCS. Dr. Ferraioli is a researcher at Fondazione IRCCS Policlinico San Matteo, Medical School, University of Pavia, (Italy). Her research interests include elastography in diffuse liver disease, non-invasive assessment of liver steatosis, ultrasound contrast agents, and Doppler in portal hypertension. She is the coordinator of the Ultrasound School at Fondazione IRCCS San Matteo Hospital Foundation, Medical School of the University of Pavia (Italy), and co-director of the EFSUMB Ultrasound Learning Center (ULC) at the same Institution.
Non-Invasive Liver Steatosis Quantification
Hepatic steatosis is the most common liver disease, with potential progression to NASH or hepatocellular carcinoma.
Attenuation Imaging (ATI) in combined with real-time ultrasound is one of the non-invasive imaging techniques used in the diagnosis of steatosis.
We will review the use of the ATI technique and its diagnostic performance compared to liver biopsy or MRI PDFF, including the latest updates for grading hepatic steatosis.
Learning objectives of the presentation:
Learn from Dr. G. Ferraioli how to evaluate liver steatosis using ultrasound imaging technique on Canon Medical devices.
Reference Doctor, Ultrasound Unit, Department of Infectious and Tropical Diseases Foundation IRCCS
Policlinico San Matteo, University of Pavia
Pavia, Italy
Background Information:
Reference Doctor, Ultrasound Unit, Department of Infectious and Tropical Diseases Foundation IRCCS. Dr. Ferraioli is a researcher at Fondazione IRCCS Policlinico San Matteo, Medical School, University of Pavia, (Italy). Her research interests include elastography in diffuse liver disease, non-invasive assessment of liver steatosis, ultrasound contrast agents, and Doppler in portal hypertension. She is the coordinator of the Ultrasound School at Fondazione IRCCS San Matteo Hospital Foundation, Medical School of the University of Pavia (Italy), and co-director of the EFSUMB Ultrasound Learning Center (ULC) at the same Institution.
Non-Invasive Liver Steatosis Quantification
Hepatic steatosis is the most common liver disease, with potential progression to NASH or hepatocellular carcinoma.
Attenuation Imaging (ATI) in combined with real-time ultrasound is one of the non-invasive imaging techniques used in the diagnosis of steatosis.
We will review the use of the ATI technique and its diagnostic performance compared to liver biopsy or MRI PDFF, including the latest updates for grading hepatic steatosis.
Learning objectives of the presentation:
Learn from Dr. G. Ferraioli how to evaluate liver steatosis using ultrasound imaging technique on Canon Medical devices.
This webinar occurred in the past. The recording will be available shortly.
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems global webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.
